Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan

ConclusionsPatients with persistent reflux symptoms and those with absent contractility and GEFV grade III or IV should receive maintenance therapy with strong acid inhibition to prevent medication-refractory RE.

Source: Journal of Gastroenterology - January 22, 2024 Category: Gastroenterology Source Type: research